Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:GolimumabGuselkumab
Belgium- Participants:18–64 years · 65+ years
- Substances:Golimumab
Rare diseases
Investigational molecules
Locations
Belgium
BelgiumLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
BelgiumA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
BelgiumA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
BelgiumStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
BelgiumStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
BelgiumA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
BelgiumA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
BelgiumA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
BelgiumStudy of ruxolitinib cream for children aged 6 to 12 years with non-segmental vitiligo
BelgiumLong-term safety study of oral povorcitinib in patients with hidradenitis suppurativa, prurigo nodularis, or vitiligo who previously participated in clinical trials
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.